Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

569
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
569
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

828
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
828
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

798
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

810
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

957
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
957
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

761
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Twenty-Five Year Outcomes of Patients Undergoing Valve Surgery for Infective Endocarditis.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Neighborhood-Level Material Resources and Risk of Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease.

The Canadian journal of cardiology·2026
Same author

Patient-physician familiarity is just as important for virtual outpatient encounters as for in-person encounters: a retrospective cohort study.

Scientific reports·2026
Same author

Evaluating the temporal and sociodemographic generalizability of the emergency heart failure mortality risk grade.

ESC heart failure·2026
Same author

Risk-Stratified Transitional Care and Cardiovascular Hospitalizations by Sex: A Secondary Analysis of a Randomized Clinical Trial.

JAMA network open·2026
Same author

A profile of heart failure in the James and Hudson's Bay region of Ontario: A retrospective cohort study.

Canadian journal of public health = Revue canadienne de sante publique·2026

Video Experimental Relacionado

Updated: May 6, 2026

Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

8.5K

Muerte cardíaca súbita relacionada con la miocardiopatía hipertrófica en jóvenes en Ontario

Adaya Weissler-Snir1,2, Katherine Allan1,2, Kristopher Cunningham3

  • 1Division of Cardiology (A.W.S., K.A., K.A.C., P.D.), St Michael's Hospital, Toronto, Canada.

Circulation
|October 22, 2019
PubMed
Resumen

La muerte súbita cardíaca (SCD) relacionada con la miocardiopatía hipertrófica (HCM) es menos común de lo que se pensaba anteriormente, especialmente en individuos jóvenes. La mayoría de los eventos de SCD ocurren durante el reposo o la actividad ligera, no durante el ejercicio extenuante.

Palabras clave:
la autopsiaMiocardiopatía hipertróficaMuerte cardíaca súbitaejercicio

Más Videos Relacionados

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.4K
Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
09:32

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

Published on: January 20, 2023

3.9K

Videos de Experimentos Relacionados

Last Updated: May 6, 2026

Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

8.5K
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.4K
Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
09:32

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

Published on: January 20, 2023

3.9K

Área de la Ciencia:

  • Cardiología
  • La genética
  • Salud pública

Sus antecedentes:

  • La cardiomiopatía hipertrófica (HCM) es una de las principales causas de muerte súbita cardíaca (SCD) en personas jóvenes.
  • Los estudios previos sobre la incidencia de ECS relacionada con la CMH y la asociación con el ejercicio carecen de datos completos de poblaciones no seleccionadas.

Objetivo del estudio:

  • Determinar la incidencia de ECS relacionada con la CMH en una población grande y no seleccionada.
  • Investigar la asociación entre el ejercicio y la ECS relacionada con la CMH.

Principales métodos:

  • Utilizó la base de datos del médico forense jefe de Ontario (2005-2016) para identificar enfermedades secundarias relacionadas con la CMH en personas de 10 a 45 años.
  • Casos confirmados de CMH a través de hallazgos de autopsia y diagnóstico clínico.
  • Se evaluaron los paros cardíacos abortados relacionados con la CMH y los datos del desfibrilador cardioverter implantable (DIC).

Principales resultados:

  • Se identificaron 44 enfermedades secundarias definidas, 3 probables y 6 posibles relacionadas con la CMH.
  • Las tasas de incidencia anual estimadas para las ECS relacionadas con la CMH oscilaron entre 0,31 y 0,39 por cada 1000 personas-año de la CMH.
  • La mayoría de las ECS (70%) ocurrieron en individuos no diagnosticados, y la mayoría de los eventos ocurrieron en reposo (64,8%) o durante la actividad ligera (18,5%).

Conclusiones:

  • La incidencia de ECS relacionada con la CMH en la población general (de 10 a 45 años) es menor que la reportada anteriormente.
  • La mayoría de las ECS relacionadas con la CMH ocurren en individuos que no son conscientes de su condición.
  • El ejercicio se asocia con poca frecuencia con eventos de ECS relacionados con la CMH.